Leadership & Pay ·
CollPlant CEO Yehiel Tal steps down as Eran Rotem takes over amid cost-cutting plan
CLGNCollPlant Biotechnologies Ltd
The Board of Directors removed Yehiel Tal as Chief Executive Officer effective immediately, citing a broader cost-reduction plan. Deputy CEO and CFO Eran Rotem was appointed to succeed him while retaining his CFO role. Tal resigned as Interim Chairman but remains on the board. The company is also discontinuing its regenerative medicine R&D activities, though production of recombinant human collagen at facilities in Israel will continue. CollPlant Biotechnologies Ltd. operates in the biotechnology sector, specializing in the production of recombinant human collagen and related bio-products.